News archive

Open Position – Leading Senior Scientist Nanotechnology Development

June 30, 2021
Lifecare AS (lifecare.attme.dev) is a stock listed Norwegian company with operations in Germany (Rhine-Main Area and Northern Germany). The company is engaged in the development of innovative biosensors based on MEMS and NEMS technologies. Current flagship product is a very small implantable continuous glucose sensor with ultra-long duration of use for patients with Diabetes mellitus. […]
Read more

Lifecare AS acquires Cantimed UG and broadens its biosensing capabilities

June 24, 2021
Lifecare AS has acquired 100% ownership of the German company Cantimed UG, following a share purchase agreement with Nanoscale Systems Nanoss GmbH. The transaction includes a license ensuring Lifecare´s access to the patented Nano3DSense technology in the medical field. This implies a continuation of Lifecare’s license covering the field of diabetes originally established in 2018 […]
Read more

Lifecare AS prolongs and amplifies collaboration with Bath University.

June 22, 2021
Lifecare is happy to announce that the collaboration with the Chemistry Department of Bath University, UK, has been prolonged and further amplified. This will ensure mutual beneficiary progress on the development of proprietary specific chemistry solutions for detection of glucose and additional analytes of interest based on the Sencell technology. In addition, Lifecare has directly […]
Read more

Webinar: Brukeropplæring i forbindelse med digital generalforsamling i Lifecare AS

May 5, 2021
Det er mulig å delta digitalt på Lifecares Generalforsamling 2021 (7. mai kl 10:00). Vi benytter en styre- og generalforsamlingsportal fra Orgbrain for digital gjennomføring. For å sikre at generalforsamlingen blir gjennomført på en mest mulig smidig måte, inviterer Lifecare og Orgbrain til et webinar der det vil bli gitt en innføring i hvordan du som aksjonær […]
Read more

The European Patent Office intends to issue new Lifecare patent

March 25, 2021
25 March 2021, Bergen – Today, Lifecare announces that The European Patent Office has issued its intent to grant Lifecare a new patent, expanding Lifecare’s patent protection in time and scope. Lifecare has reviewed the examining division’s comments to the patent application and concludes that the suggested cosmetic changes are acceptable. On this base, Lifecare […]
Read more